ID PGDS$HUMAN STANDARD; PRT; 1089 AA. AC P16234; DT 01-APR-1990 (REL. 14, CREATED) DT 01-APR-1990 (REL. 14, LAST SEQUENCE UPDATE) DT 01-APR-1990 (REL. 14, LAST ANNOTATION UPDATE) DE PLATELET-DERIVED GROWTH FACTOR RECEPTOR BETA PRECURSOR (EC 2.7.1.112). OS HUMAN (HOMO SAPIENS). OC EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; TETRAPODA; MAMMALIA; OC EUTHERIA; PRIMATES. RN [1] (SEQUENCE FROM N.A.) RA MATSUI T., HEIDARAN M., MIKI T., POPESCU N., LA ROCHELLE W., RA KRAUS M., PIERCE J., AARONSON S.; RL SCIENCE 243:800-804(1989). CC -!- FUNCTION: THIS RECEPTOR BINDS PLATELET-DERIVED GROWTH FACTOR AND CC HAS A TYROSINE-PROTEIN KINASE ACTIVITY. CC -!- SIMILARITY: BELONGS TO THE CSF-1/PDGF RECEPTOR FAMILY OF TYROSINE- CC PROTEIN KINASES. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M21574; M21574. DR PROSITE; PS00107; PROTEIN_KINASE_ATP. DR PROSITE; PS00109; PROTEIN_KINASE_TYR. DR PROSITE; PS00240; RECEPTOR_TYR_KIN_III. KW TYROSINE-PROTEIN KINASE; RECEPTOR; TRANSMEMBRANE; GLYCOPROTEIN; KW TRANSFERASE; PHOSPHORYLATION; ATP-BINDING; SIGNAL. FT SIGNAL 1 24 FT CHAIN 25 1089 PDGF RECEPTOR. FT DOMAIN 25 526 EXTRACELLULAR (PUTATIVE). FT TRANSMEM 527 549 PUTATIVE. FT DOMAIN 550 1089 CYTOPLASMIC (CATALYTIC). FT NP_BIND 599 607 ATP (BY SIMILARITY). FT BINDING 627 627 ATP (BY SIMILARITY). FT MOD_RES 849 849 PHOSPHORYLATION (AUTO-) (BY SIMILARITY). FT CARBOHYD 42 42 POTENTIAL. FT CARBOHYD 76 76 POTENTIAL. FT CARBOHYD 103 103 POTENTIAL. FT CARBOHYD 179 179 POTENTIAL. FT CARBOHYD 353 353 POTENTIAL. FT CARBOHYD 359 359 POTENTIAL. FT CARBOHYD 458 458 POTENTIAL. FT CARBOHYD 468 468 POTENTIAL. SQ SEQUENCE 1089 AA; 122668 MW; 6396990 CN; MGTSHPAFLV LGCLLTGLSL ILCQLSLPSI LPNENEKVVQ LNSSFSLRCF GESEVSWQYP MSEEESSDVE IRNEENNSGL FVTVLEVSSA SAAHTGLYTC YYNHTQTEEN ELEGRHIYIY VPDPDVAFVP LGMTDYLVIV EDDDSAIIPC RTTDPETPVT LHNSEGVVPA SYDSRQGFNG TFTVGPYICE ATVKGKKFQT IPFNVYALKA TSELDLEMEA LKTVYKSGET IVVTCAVFNN EVVDLQWTYP GEVKGKGITM LEEIKVPSIK LVYTLTVPEA TVKDSGDYEC AARQATREVK EMKKVTISVH EKGFIEIKPT FSQLEAVNLH EVKHFVVEVR AYPPPRISWL KNNLTLIENL TEITTDVEKI QEIRYRSKLK LIRAKEEDSG HYTIVAQNED AVKSYTFELL TQVPSSILDL VDDHHGSTGG QTVRCTAEGT PLPDIEWMIC KDIKKCNNET SWTILANNVS NIITEIHSRD RSTVEGRVTF AKVEETIAVR CLAKNLLGAE NRELKLVAPT LRSELTVAAA VLVLLVIVII SLIVLVVIWK QKPRYEIRWR VIESISPDGH EYIYVDPMQL PYDSRWEFPR DGLVLGRVLG SGAFGKVVEG TAYGLSRSQP VMKVAVKMLK PTARSSEKQA LMSELKIMTH LGPHLNIVNL LGACTKSGPI YIITEYCFYG DLVNYLHKNR DSFLSHHPEK PKKELDIFGL NPADESTRSY VILSFENNGD YMDMKQADTT QYVPMLERKE VSKYSDIQRS LYDRPASYKK KSMLDSEVKN LLSDDNSEGL TLLDLLSFTY QVARGMEFLA SKNCVHRDLA ARNVLLAQGK IVKICDFGLA RDIMHDSNYV SKGSTFLPVK WMAPESIFDN LYTTLSDVWS YGILLWEIFS LGGTPYPGMM VDSTFYNKIK SGYRMAKPDH ATSEVYEIMV KCWNSEPEKR PSFYHLSEIV ENLLPGQYKK SYEKIHLDFL KSDHPAVARM RVDSDNAYIG VTYKNEEDKL KDWEGGLDEQ RLSADSGYII PLPDIDPVPE EEDLGKRNRH SSQTSEESAI ETGSSSSTFI KREDETIEDI DMMDDIGIDS SDLVEDSFL //